China, Sept. 23 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'RCT of Sirolimus for SLE-ITP-1st Phase'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600133100
Registration Time: 2026/09/22
Type: Interventional study
Primary Sponsor: Peking Union Medical College Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=329029
Published by HT Digital Content Services with permission from Health Daily Digest....